Here is What Hedge Funds Think About Affymax, Inc. (AFFY)
Is Affymax, Inc. (NASDAQ:AFFY) a first-rate investment now? The smart money is taking a pessimistic view. The number of long hedge fund positions were...
Posts Tagged ‘NASDAQ:AFFY’
Affymax, Inc. (AFFY), Coinstar, Inc. (CSTR): The NASDAQ Composite (.IXIC)’s Five Most Hated Stocks
Short-sellers certainly huffed and puffed with all of their might in May, but it wasn’t meant to be: The tech-heavy NASDAQ Composite (INDEXNASDAQ...
Hedge Funds Are Selling Affymax, Inc. (AFFY) – Northwest Biotherapeutics, Inc (NWBO), Celsion Corporation (CLSN)
Is Affymax, Inc. (NASDAQ:AFFY) the right pick for your portfolio? Hedge funds are becoming less confident. The number of bullish hedge fund bets dropped...
ZIOPHARM Oncology Inc. (ZIOP), Ariad Pharmaceuticals, Inc. (ARIA): 3 Reasons Investors Are Scared of Biotech Stocks
Biotechs offer the possibility of monster returns. Overnight doubles aren’t out of the question. Triples and quadruples as a drug successfully progresses...
Amgen, Inc. (AMGN), Affymax, Inc. (AFFY): The Danger of the One-Hit Wonder
The drug development field is a potentially lucrative, although always dangerous area for small companies and their investors to participate in. The development...
3 Can’t-Miss Health-Care Events This Week: Synageva BioPharma Corp (GEVA), Amedisys Inc (AMED), Gentiva Health Services, Inc. (GTIV)
You won’t often hear me say this, but it’s a pretty quiet week on the health-care front. There are a few notable conferences kicking off next...
This Week in Biotech: Dynavax Technologies Corporation (DVAX), Zogenix, Inc. (ZGNX)
With the SPDR S&P Biotech Index up 23% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...
3 Stocks That May Help Determine the Dow’s Moves Today: Affymax, Inc. (AFFY) and More
The Dow Jones Industrial Average finished strong last week, and eked out a closing price just above the 14,000 mark. The rally continued this morning,...
Behold the Dangers of a One-Trick Pony: Affymax, Inc. (AFFY) and More
At the end of last year, I proclaimed Omontys — an erythropoiesis-stimulating agent, or ESA, that aids in the formation of red blood cells —...
Down 85%! Why Affymax, Inc. (AFFY) is Getting Crushed This Morning
Look out below Affymax, Inc. (NASDAQ:AFFY) investors. The company pulled its only drug off of the market, and shares of the company are indicated to fall...
Dow Jones Industrial Average (.DJI)’s Bumpy Ride Keeps It in Positive Territory
The Dow Jones Industrial Average (INDEX:.DJI) has had a wild ride this morning, but stayed up nevertheless. With the index poised to break the 14,000...
Affymax, Inc. (AFFY) Hit Hard… and Then Rebounds?
Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case...
5 Health Care Stocks Slumping in 2013: NPS Pharmaceuticals, Inc. (NPSP), OraSure Technologies, Inc. (OSUR)
Stocks are rolling along unchallenged, surging to highs not seen since 2007. Investors are partying like it’s before the recession, but with many...
Has Amgen, Inc. (AMGN) Become the Perfect Stock?
Every investor would love to stumble upon the perfect stock. But will you ever really find a stock that provides everything you could possibly want? One...
What’s Next for Affymax, Inc. (AFFY)?
Affymax, Inc. (NASDAQ:AFFY) received its first Food and Drug Administration approval last spring with Omontys for anemia in dialysis patients. The drug...
